Volume 2 Issue 3 2019

• Open Access Original Research

  Poly (ADP-ribose) polymerase (PARP) inhibitors as chemosensitizing compounds for the treatment of drug resistant cancers

  Narayanan Silpa, Teng Qiu-Xu, Koya Jagadish, Wang Jingquan, ... Chen Zhe-Sheng

  J. Mol. Clin. Med. 2019, 2(3), 55–67; https://doi.org/10.31083/j.jmcm.2019.03.0303

  Abstract Full Text PDF(4.45MB)

  91

  Downloads

  5

  Citations

  172

  Views
• Open Access Original Research

  KIT and PDGFRA inhibitor avapritinib (BLU-285) overcomes ABCB1- and ABCBG2-mediated MDR in cancer cells

  Gupta Pranav, V. Ashar Yunali, Teng Qiu-Xu, Lei Zining, ... Chen Zhe-Sheng

  J. Mol. Clin. Med. 2019, 2(3), 69–78; https://doi.org/10.31083/j.jmcm.2019.03.0301

  Abstract Full Text PDF(1.07MB)

  22

  Downloads

  78

  Views
• Open Access Original Research

  Immunotherapy in pediatric brain tumors: considerations, challenges and future directions

  S. Kruithof Eline, van der Lugt Jasper, Hulleman Esther

  J. Mol. Clin. Med. 2019, 2(3), 79–91; https://doi.org/10.31083/j.jmcm.2019.03.0302

  Abstract Full Text PDF(559.77KB)

  31

  Downloads

  77

  Views
• Open Access Original Research

  The use of biological glue (Starsil® Hemostat) in robotic partial nephrectomy: a safety and efficacy study

  Zisman Ariel, Nativ Omri, Malshy Kamil, Sadeh Omer, ... E. Amiel Gilad

  J. Mol. Clin. Med. 2019, 2(3), 93–96; https://doi.org/10.31083/j.jmcm.2019.03.0213

  Abstract Full Text PDF(261.95KB)

  62

  Downloads

  244

  Views